eLifeNeurosciencePeer-reviewed journal article
Repressing PTBP1 is incapable to convert reactive astrocytes to dopaminergic neurons in a mouse model of Parkinson's disease
Weizhao Chen, Qiongping ZhengiD, Qiaoying HuangiD, Shanshan MaiD, Mingtao Li
Abstract
Lineage reprograming of resident glia cells to induced dopaminergic neurons (iDAns) holds attractive prospect for cell-replacement therapy of Parkinsons disease (PD). Recently, whether repressing polypyrimidine tract binding protein 1 (PTBP1) could truly achieve efficient astrocyte-to-iDAn conversion in substantia nigra and striatum aroused widespread controversy. Although reporter positive iDAns were observed by two groups after delivering adeno-associated virus (AAV) expressing a reporter with shRNA or Crispr-CasRx to repress astroglial PTBP1, the possibility of AAV leaking into endogenous DAns could not be excluded without using a reliable lineage tracing method. By adopting stringent lineage tracing strategy, two other studies showed that neither knockdown nor genetic deletion of quiescent astroglial PTBP1 fails to obtain iDAns under physiological condition. However, the role of reactive astrocyte might be underestimated since upon brain injury, reactive astrocyte could acquire certain stem cell hallmarks which may facilitate the lineage conversion process. Therefore, whether reactive astrocytes could be genuinely converted to DAns after PTBP1 repression in a PD model needs further validation. In this study, we used Aldh1l1-CreERT2-mediated specific astrocyte-lineage tracing method to investigate whether reactive astrocytes could be converted to DAns in the 6-OHDA PD model. However, we found that no astrocyte-originated DAn was generated after effective knockdown of astroglial PTBP1 either in the substantia nigra or in the striatum, while AAV "leakage" to nearby neurons was observed. Our results further confirmed that repressing PTBP1 is unable to convert astrocytes to DAns no matter in physiological or PD-related pathological conditions. Graphic abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=69 SRC="FIGDIR/small/468309v2_ufig1.gif" ALT="Figure 1"> View larger version (17K): org.highwire.dtl.DTLVardef@fa2fa5org.highwire.dtl.DTLVardef@14e328eorg.highwire.dtl.DTLVardef@d93faborg.highwire.dtl.DTLVardef@e32225_HPS_FORMAT_FIGEXP M_FIG C_FIG HighlightsO_LIAAV-shPtbp1 rapidly and efficiently induces viral-reporter-labeled DAns in mouse brain under physiological condition C_LIO_LIViral-reporter-positive DAns are not originated from PTBP1 repressed and lineage traced reactive astrocytes in a mouse PD model C_LI
- Citations
- 89
- FWCI
- 6.20
- Field percentile
- top 2%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Base editing of Ptbp1 in neurons alleviates symptoms in a mouse model for Parkinson's disease
Desirée Böck, Maria Wilhelm, … Gerald Schwank·eLifePeer-reviewed·Dec 13, 2024
- Therapeutic Reversal of Chemically Induced Parkinson Disease by Converting Astrocytes into Nigral Neurons
Hao Qian, Jing Hu, … Xiang‐Dong Fu·bioRxiv·Apr 6, 2020
- Downregulating PTBP1 fails to convert astrocytes into hippocampal neurons and to alleviate symptoms in Alzheimer's mouse models
Tiantian Guo, Xinjia Pan, … Yingjun Zhao·Journal of NeurosciencePeer-reviewed·Aug 9, 2022
- Ptbp1 knockdown in mouse striatum did not induce astrocyte-to-neuron conversion using HA-tagged labeling system
Guixiang Yang, Zixiang Yan, … Kailun Fang·Gene TherapyPeer-reviewed·Jan 31, 2023
- Loss of the Parkinson's disease-associated protein DJ-1 impacts dopamine metabolism in astrocytes
Annika Wagener, Naiyareen Fareeza Mayeen, … Lena F. Burbulla·bioRxiv·Nov 2, 2025
- Mitochondrial DNA damage in substantia nigra parscompacta astrocytes exacerbates dopaminergic neuron lossin a 6-hydroxydopamine mouse model of parkinsonism
Daniela A. Ayala, Grace M Hall, … Rahul Srinivasan·Cellular and Molecular NeurobiologyPeer-reviewed·Mar 19, 2026